Procter & Gamble Hygiene and Health Care Limited
NSE: PGHHPersonal Care
Share price
₹6,857.00
-0.92% close of 8 Oct 2026
Business score
How strong the business is, in one number. The parts behind it are in Pro.
72
out of 100 · worked out 8 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹21,942 Cr
P/E ratio
27.8
P/B ratio
29.6
ROCE
157.0%
ROE
114.9%
Dividend yield
3.3%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Sales fell 1.5% over the past year. Meanwhile what it keeps of every 100 rupees of sales improved from 20.3% to 24.7% over the last four years.
Whether it grew faster than its sector
It grew 11.9% a year against a sector median of 9.9% — 2.0 percentage points faster.
Room to re-rate, or risk of de-rating
At 27.8× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 35.9×, across 5 companies. It is against its own five-year median of 73.3×, the 0th percentile of its own range.
Whether growth justifies the valuation
Priced at 2.0 times its growth rate, on earnings growth of 14%.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| Procter & Gamble Hygiene and Health Care Limited — this one | 14%/yr | 27.8× | ₹2.0 |
| Godrej Consumer Products | 5%/yr | 42.5× | ₹8.5 |
| Dabur India | 4%/yr | 33.6× | ₹8.4 |
| Cupid Limited | — | 348.8× | — |
| Colgate-Palmolive India | 8%/yr | 34.8× | ₹4.3 |
| Gillette India Limited | 31%/yr | 35.9× | ₹1.2 |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies the exchange files under the same label (Personal Care), it ranks 1 of 10 on returns, 4 of 10 on growth, 4 of 10 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
A wide advantage: it earns 157% on capital, ahead of 90% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
Yes — Over the last five years it made ₹3391 crore of cash from the business, spent ₹223 crore on plant and equipment, and returned ₹3423 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 12 years, about 104 arrived as cash (before interest, which is why it can exceed the profit).
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
9 of 9 checks clear · 100%
Latest result · Q1 FY27
What the last results showed. Whether management kept its word is in Pro.
Sales slipped 5% from a year ago and profit fell 34%
Announced 29 Jul 2026 · Standalone
Revenue
₹891 Cr
Revenue vs last year
-4.9%
Revenue vs last quarter
-5.3%
Net profit
₹126 Cr
Profit vs last year
-34.2%
Profit vs last quarter
-17.5%
Net margin
14.2%
EPS
₹38.90
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹21,942 Cr
- Prev close
- ₹6,857.00
- 52w High
- ₹14,352
- 52w Low
- ₹6,579
- Enterprise value
- ₹21,375 Cr
- Beta
- 0.3
- Price CAGR 1y
- -52.0%
- Price CAGR 3y
- -27.0%
- Price CAGR 5y
- -13.0%
- Price CAGR 10y
- 0.0%
Ratios
- Return on assets
- 47.5%
- PEG ratio
- 2.0
- P/E ratio
- 27.8
- P/B ratio
- 29.6
- EV / EBITDA
- 19.9
- Industry P/E
- 34.7
- ROCE
- 157.0%
- ROCE 5y average
- 116.8%
- ROE
- 114.9%
- Debt / Equity
- 0.0
- Interest coverage
- 130.7
- Dividend yield
- 3.3%
- ROE 3y average
- 89.0%
- ROE last year
- 115.0%
Annual P&L
- Annual revenue
- ₹4,290 Cr
- Annual profit
- ₹856 Cr
- Operating margin
- 27.0%
- Net profit margin
- 20.0%
- EBITDA margin
- 27.3%
- Sales growth 3y
- 3.1%
- Sales growth 5y
- 3.7%
- Profit growth 3y
- 14.0%
- Profit growth 5y
- 14.0%
- EPS
- ₹264
- Sales growth TTM
- -2.0%
- Profit growth TTM
- -5.0%
- Dividend payout
- 97.0%
Quarter P&L
- Sales latest quarter
- ₹891 Cr
- Profit latest quarter
- ₹126 Cr
- YoY quarterly sales growth
- -4.9%
- YoY quarterly profit growth
- -34.4%
- OPM latest quarter
- 19.1%
Balance Sheet
- Book Value
- ₹235
- Face Value
- ₹10.0
- Total debt
- ₹1 Cr
- Total cash
- ₹568 Cr
- Borrowings
- ₹1 Cr
- Reserves / Equity
- 22.5
Cash Flow
- Operating cash flow
- ₹924 Cr
- Free cash flow
- ₹893 Cr
- FCF yield
- 4.0%
- Net cash flow
- ₹91 Cr
Shareholding
- Promoter holding
- 70.6%
- FII holding
- 1.0%
- DII holding
- 15.6%
- Public holding
- 12.8%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| Godrej Consumer | 870.00 | 42.9 | 89,028 | 2.32 | 504.5 | 10.6 | 4,225.5 | 15.4 | 18.8 |
| Dabur India | 382.85 | 34.2 | 67,916 | 2.17 | 586.2 | 15.0 | 3,764.4 | 10.6 | 20.3 |
| Colgate-Palmoliv | 1,764.15 | 35.1 | 47,982 | 2.74 | 343.1 | 7.8 | 1,603.3 | 11.8 | 108.0 |
| Cupid | 352.75 | 345.1 | 47,433 | 0.00 | 44.2 | 194.0 | 157.0 | 142.5 | 33.9 |
| Gillette India | 7,245.75 | 35.4 | 23,614 | 2.50 | 159.5 | 9.4 | 783.0 | 10.8 | 90.7 |
| P & G Hygiene | 6,903.50 | 28.3 | 22,409 | 3.28 | 126.3 | -34.3 | 891.5 | -4.9 | 157.2 |
| Emami | 373.40 | 21.5 | 16,299 | 2.72 | 138.9 | -16.4 | 1,039.2 | 14.9 | 28.1 |
| Median | 443.65 | 37.3 | 15,906 | 0.34 | 90.5 | 15.0 | 756.0 | 15.4 | 30.2 |
Competes with: Bajaj Consumer Care Limited, Colgate-Palmolive India, Cupid Limited, Dabur India, Emami Limited, Gillette India Limited, Godrej Consumer Products, Honasa Consumer Limited, JHS Svendgaard Laboratories Limited
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 853 | 1,138 | 1,133 | 1,002 | 932 | 1,135 | 1,248 | 992 | 937 | 1,150 | 1,262 | 941 | 891 |
| Expenses | 638 | 853 | 824 | 745 | 813 | 845 | 877 | 782 | 671 | 865 | 860 | 723 | 721 |
| Material Cost | 175 | 164 | 197 | 206 | 171 | 200 | |||||||
| Change in Inventories | 9.30 | -26 | 36 | -0.17 | -7.11 | -33 | |||||||
| Purchases of Stock-in-Trade | 210 | 202 | 212 | 217 | 193 | 213 | |||||||
| Employee Cost | 49 | 48 | 49 | 62 | 57 | 54 | |||||||
| Other Expenses | 338 | 281 | 372 | 376 | 310 | 287 | |||||||
| Operating Profit | 215 | 285 | 310 | 257 | 118 | 290 | 371 | 210 | 266 | 285 | 402 | 218 | 170 |
| OPM % | 25 | 25 | 27 | 26 | 13 | 26 | 30 | 21 | 28 | 25 | 32 | 23 | 19 |
| Other Income | 10 | 16 | 16 | 14 | 7 | 8 | 10 | 19 | 8 | 10 | 12 | 12 | 9 |
| Exceptional items (within Other Income) | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| Interest | 3 | 2 | 3 | 22 | -0 | 2 | 7 | 6 | 0 | 4 | 3 | 3 | 0 |
| Depreciation | 15 | 14 | 14 | 15 | 13 | 12 | 10 | 10 | 9 | 9 | 10 | 10 | 10 |
| Profit before tax | 207 | 284 | 309 | 234 | 112 | 285 | 364 | 213 | 265 | 282 | 402 | 218 | 170 |
| Tax % | 27 | 26 | 26 | 34 | 28 | 26 | 26 | 27 | 27 | 26 | 25 | 30 | 26 |
| Net Profit | 151 | 211 | 229 | 154 | 81 | 212 | 269 | 156 | 192 | 210 | 301 | 153 | 126 |
| EPS in Rs | 47 | 65 | 71 | 48 | 25 | 65 | 83 | 48 | 59 | 65 | 93 | 47 | 39 |
| Diluted EPS in Rs | 48 | 59 | 65 | 93 | 47 | 39 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,334 | 2,275 | 2,320 | 2,455 | 2,947 | 3,002 | 3,574 | 3,901 | 3,918 | 4,206 | 3,374 | 4,290 | 4,245 |
| Expenses | 1,838 | 1,667 | 1,646 | 1,834 | 2,329 | 2,396 | 2,688 | 3,069 | 3,048 | 3,230 | 2,503 | 3,119 | 3,170 |
| Material Cost | 738 | ||||||||||||
| Change in Inventories | 3.08 | ||||||||||||
| Purchases of Stock-in-Trade | 824 | ||||||||||||
| Employee Cost | 215 | ||||||||||||
| Other Expenses | 1,339 | ||||||||||||
| Operating Profit | 495 | 608 | 675 | 622 | 618 | 606 | 886 | 832 | 869 | 976 | 871 | 1,171 | 1,075 |
| OPM % | 21 | 27 | 29 | 25 | 21 | 20 | 25 | 21 | 22 | 23 | 26 | 27 | 25 |
| Other Income | 64 | 85 | 67 | 18 | 45 | 42 | 38 | 23 | 40 | 47 | 37 | 42 | 44 |
| Exceptional items (within Other Income) | 0 | ||||||||||||
| Interest | 6 | 6 | 10 | 5 | 5 | 6 | 6 | 11 | 11 | 27 | 14 | 9.45 | 10 |
| Depreciation | 53 | 52 | 60 | 52 | 50 | 48 | 48 | 53 | 58 | 56 | 32 | 37 | 38 |
| Profit before tax | 501 | 636 | 672 | 582 | 607 | 594 | 870 | 790 | 839 | 939 | 862 | 1,167 | 1,072 |
| Tax % | 31 | 34 | 36 | 36 | 31 | 27 | 25 | 27 | 19 | 28 | 26 | 27 | |
| Net Profit | 346 | 422 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 857 | 791 |
| EPS in Rs | 107 | 130 | 133 | 115 | 129 | 133 | 201 | 177 | 209 | 208 | 196 | 264 | 244 |
| Diluted EPS in Rs | 264 | ||||||||||||
| Dividend Payout % | 28 | 28 | 292 | 35 | 68 | 79 | 157 | 90 | 89 | 123 | 89 | 97 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- 7%
- 5 years
- 4%
- 3 years
- 3%
- TTM
- -2%
Compounded profit growth
- 10 years
- 9%
- 5 years
- 14%
- 3 years
- 14%
- TTM
- -5%
Stock price CAGR
- 10 years
- 0%
- 5 years
- -13%
- 3 years
- -27%
- 1 year
- -52%
Return on equity
- 10 years
- 60%
- 5 years
- 83%
- 3 years
- 89%
- Last year
- 115%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 1,196 | 1,619 | 494 | 773 | 877 | 1,125 | 682 | 705 | 914 | 742 | 705 | 721 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 4 | 3 | 2 | 1 |
| Other Liabilities | 719 | 515 | 634 | 620 | 708 | 671 | 915 | 940 | 1,187 | 1,081 | 1,015 | 1,049 |
| Total Liabilities | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 | 1,804 |
| Fixed Assets | 309 | 317 | 286 | 250 | 234 | 206 | 184 | 164 | 170 | 139 | 131 | 163 |
| CWIP | 39 | 35 | 41 | 21 | 15 | 22 | 38 | 44 | 23 | 28 | 41 | 21 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,600 | 1,814 | 834 | 1,154 | 1,368 | 1,600 | 1,411 | 1,475 | 1,945 | 1,692 | 1,583 | 1,619 |
| Total Assets | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 | 1,804 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 426 | 352 | 445 | 415 | 413 | 474 | 863 | 573 | 826 | 470 | 598 | 924 |
| Cash from Investing Activity | 28 | 221 | 149 | -19 | 34 | 75 | 7 | -27 | -10 | 1 | -34 | 11 |
| Cash from Financing Activity | -105 | -122 | -1,559 | -106 | -314 | -190 | -1,106 | -569 | -477 | -861 | -671 | -845 |
| Net Cash Flow | 349 | 452 | -964 | 290 | 134 | 358 | -236 | -23 | 339 | -390 | -107 | 91 |
| Free Cash Flow | 348 | 300 | 401 | 377 | 410 | 423 | 832 | 523 | 781 | 427 | 544 | 893 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 24 | 21 | 22 | 22 | 20 | 15 | 18 | 20 | 21 | 33 | 21 |
| Inventory Days | 47 | 53 | 71 | 48 | 60 | 68 | 78 | 55 | 48 | 51 | 64 | 51 |
| Days Payable | 148 | 134 | 145 | 156 | 162 | 175 | 237 | 183 | 213 | 193 | 235 | 197 |
| Cash Conversion Cycle | -83 | -57 | -53 | -87 | -79 | -87 | -144 | -110 | -145 | -121 | -138 | -126 |
| Working Capital Days | 4 | 8 | -15 | -23 | -12 | -21 | -39 | -34 | -53 | -32 | -30 | -31 |
| ROCE % | 46 | 45 | 64 | 89 | 73 | 58 | 94 | 110 | 101 | 112 | 104 | 157 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash
-567inr_cr
2026-03-31
guarantees / comfort given for promoter, promoter group, directors and KMP
0.00cr
2026-03-31
loans outstanding to promoter, promoter group, directors and KMP (governance filing)
0.00cr
2026-03-31
security given for the borrowing of promoter, promoter group, directors and KMP
0.00cr
2026-03-31
FY revenue / permanent employees + workers, same basis (calc)
11,11,39,896inr
2026-03-31
News
News and filings about Procter & Gamble Hygiene and Health Care Limited. Open one to see why it matters.
No recent news for this company.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Depends on the price of
- Crude Oil Brent
Buys from
- GHCL Limited · soda ash
- Gandhar Oil Refinery (India) Limited · White oils / mineral oil for personal care
- Huhtamaki India Limited · Flexible packaging for hygiene & healthcare products
- Ultramarine & Pigments Limited · Surfactants for detergent / personal-care FMCG — P&G Hyderabad facility
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Fast Moving Consumer Goods
- Industry
- Personal Care
- Classification
- Fast Moving Consumer Goods › Personal Care
- ISIN
- INE179A01014
Plants
- P&G Baddi plant
- P&G Goa (Honda) plant
- P&G Kundaim plant, Goa
News impact
Big market events that reach Procter & Gamble Hygiene and Health Care Limited, and how the effect spreads.
1 Oct, 11:57 IST · Market event · medium impact
India Forecasts Normal Winter Rain Despite Weak Monsoon Season
India expects normal winter rains despite a weak summer monsoon, helping winter farmers, fertiliser makers and rural shops, though weak summer rains still hurt summer crops.
Who it hits first
- The weather office expects normal winter rain even though summer monsoon rain ended about 12% below normal.
- A normal winter helps winter-sown crops (called rabi, like wheat) after a weak summer, so farm incomes hold up better.
- Godrej Agrovet, which sells animal feed and farm inputs, and Parag Milk Foods, which sells milk and cheese, sit closest to that farm relief.
Who may gain
- Farm input sellers like Godrej Agrovet that sell feed and crop care for winter sowing
- Milk and food makers like Parag Milk Foods and Hindustan Unilever that gain when village spending steadies
- Sugar makers like Balrampur Chini Mills that need good rain for cane, plus daily goods sellers as farm cash flows
Along the supply chain
Downstream
Milk collectors, grain buyers, village stores and city packers move more winter milk, wheat and sugar if the rain arrives as forecast.
Upstream
Seed, feed, fertiliser and farm-chemical sellers see steadier winter orders as sowing hopes improve after a weak summer.
Where demand moves
Business
Farmers sow more winter wheat and buy more feed, seed and crop care, while village shops sell more milk, soap and packaged food as farm cash steadies.
Capital
Investors favour rural-linked food and farm shares on a kind winter forecast, so money tilts toward steady staples makers while summer-crop losses cap the mood.
How it spreads across sectors
Agriculture
positive — better rabi hopes aid farm output after a weak summer
Fast Moving Consumer Goods
positive — steadier farm incomes support village buying of milk, food and soaps
Fertilizers
positive — normal winter rain supports winter sowing and fertiliser use, though the pack lists no Fertilizer members
Sugar
positive — cane and sugar output hopes improve with winter moisture
Two-wheelers
positive — steadier farm cash can aid bike and tractor buying at the margin
A pattern seen before
Cascade chain
- Summer monsoon -12% → kharif and reservoir stress
- Normal winter rain forecast → rabi sowing support
- Rabi acreage → fertilizer, feed and seed demand
- Farm cash → rural FMCG and dairy volumes
Pattern name
Monsoon Cascade
Patterns
- Monsoon Cascade
Sectors queried
- FMCG
When it plays out
Immediate
In 1–7 days, rural-linked food and farm shares firm on the kind winter forecast while traders watch reservoir levels.
Medium term
In 1–6 months, actual winter rain decides wheat, milk and sugar output and village spending.
Short term
In 1–4 weeks, winter sowing data shows whether farmers act on the forecast after a weak summer.
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Dividends
| 1 Sep 2026 | unspecified | ₹60 |
|---|---|---|
| 5 Feb 2026 | special | ₹25 |
| 5 Feb 2026 | interim | ₹170 |
| 28 Aug 2025 | unspecified | ₹65 |
| 20 Feb 2025 | interim | ₹110 |
| 19 Nov 2024 | unspecified | ₹95 |
| 9 Feb 2024 | special | ₹60 |
| 9 Feb 2024 | interim | ₹100 |
Splits, bonuses & buybacks
- daily-prices repair: 8 rows from NSE's archive (replace 1, delete 0, insert 7), 2016-10-30..2026-02-01 (docs/flat_day_repair.md)1× · 30 Oct 2016
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Annual report · 2025-2617 Aug 2026
- Annual report · 2024-2526 Aug 2025
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.